Intellipharmaceutics International Inc (NASDAQ:IPCI)

0.4199
Delayed Data
As of 10:30am ET
 -0.01 / -2.33%
Today’s Change
0.40
Today|||52-Week Range
2.92
-47.51%
Year-to-Date
No recent news for Intellipharmaceutics International Inc.

Today’s Trading

Previous close0.43
Today’s open0.42
Day’s range0.40 - 0.44
Volume102,393
Average volume (3 months)324,971
Market cap$21.9M
Data as of 10:30am ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+23.68%
Earnings growth (this year)+36.21%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+144.97%
P/E ratioNM
Price/Sales4.77
Price/Book56.59

Competitors

 Today’s
change
Today’s
% change
SLNOSoleno Therapeutics ...+0.09+5.34%
CTXRCitius Pharmaceutica...-0.13-4.76%
VKTXViking Therapeutics ...-0.04-0.97%
ARCTArcturus Therapeutic...+0.05+0.96%
Data as of 11:04am ET, 04/25/2018

Financials

Last reporting dateApril 25, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$5.5M
Annual profit (last year)-$8.9M
Net profit margin-160.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts